Prosecution Insights
Last updated: October 04, 2026
Application No. 18/608,048

COMPOSITE POLYMER FILM MATERIAL BASED ON TUNGSTEN/COPPER/SULFUR CLUSTER COMPOUND, PREPARATION METHOD AND USE THEREOF IN THIRD-ORDER NONLINEAR OPTICS

Non-Final OA §101§112
Filed
Mar 18, 2024
Priority
Jul 13, 2022 — CN 202210821687.X +1 more
Examiner
RHOADES, DEREK JAMES
Art Unit
Tech Center
Assignee
Soochow University
OA Round
1 (Non-Final)
71%
Grant Probability
Favorable
1-2
OA Rounds
1y 0m
Est. Remaining
88%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allowance Rate
57 granted / 80 resolved
+11.3% vs TC avg
Strong +17% interview lift
Without
With
+17.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
29 currently pending
Career history
90
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
42.5%
+2.5% vs TC avg
§102
13.9%
-26.1% vs TC avg
§112
24.4%
-15.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 80 resolved cases

Office Action

§101 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Status Claims 1-10 are pending. No claims have been amended. No claims have been cancelled. Thus claims 1-10 represent all claims currently under consideration. Priority Domestic Priority data as claimed by Applicant: This application is a CON of PCT/CN2023/106898 (07/12/2023) Foreign Applications: CHINA 202210821687.X (07/13/2022) Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Information Disclosure Statement The listing of references in the specification is not a proper information disclosure statement. 37 CFR 1.98(b) requires a list of all patents, publications, or other information submitted for consideration by the Office, and MPEP § 609.04(a) states, "the list may not be incorporated into the specification but must be submitted in a separate paper." Therefore, unless the references have been cited by the examiner on form PTO-892, they have not been considered. Claim Objections Claim 2 is objected to because of the following informalities: In line 2, “comprises steps of” should read “comprising the steps of”. Claim 6 is objected to because of the following informalities: In line 2, “comprises steps of” should read “comprising the steps of”. Appropriate correction is required. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claim 10 is rejected under 35 U.S.C. 101 because the claimed invention is directed to non-statutory subject matter. Claim 10 does not fall within at least one of the four categories of patent eligible subject matter because it is unclear whether the claim is intended to encompass a product or a process. Specifically, claim 10 recites “Use of the composite polymer film material…” The claim fails to recite any active, positive steps. MPEP § 2173.05(q)(I) states that “A "use" claim may be rejected under 35 U.S.C 101 and/or 112. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-10 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites a compound having a chemical formula [RWS3Cu2(La)]n(M)n, wherein the variable La that has the following structural formula: PNG media_image1.png 509 790 media_image1.png Greyscale The shading of the structural formula La is unclear and renders the formula difficult to interpret, and this ambiguity renders the instant claim indefinite. Further regarding the structural formula La of claim 1, it is unclear as written whether or not the dashed bonds represent covalent bonds, and it is also unclear what atom(s) these bonds are connected to. This ambiguity renders the scope of the structure comprising the claimed chemical formula unclear and the instant claim indefinite. Fig. 1 of the present application shows that La is formed from the reaction of L (1,4-di(pyridin-4-yl)buta-1,3-diyne), [Et4N][Tp*WS3], and either Cu(ReO4) or Cu(OTf), respectively, wherein one of the alkyne moieties from the ligand L appears to react to form a 5-membered metallacycle ring with two S atoms, generating a (Z)-alkene in the process. However, it is unclear whether or not the structure represented by the dashed bonds are limited to bonding to an S atom. Regarding claims 2-10, these dependent claims do not resolve the indefiniteness of claim 1 detailed above. Claim 10 recites “Use of the composite polymer film material according to claim 5 in the preparation of a third-order nonlinear optical material.” This claim is indefinite because it merely recites a use without any active, positive steps delimiting how this use is actually practiced. MPEP § 2173.05(q) states that “Attempts to claim a process without setting forth any steps involved in the process generally raises an issue of indefiniteness under 35 U.S.C. 112(b) or pre-AIA 35 U.S.C. 112, second paragraph.” The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claims 2-3 are rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claims 2-3 recite the broad genus “cuprous salt” without further limiting the structure of the claimed Cu(I)-derived salt. However, the cluster compound having a chemical formula of [RWS3Cu2(La)]n(M)n of claim 1 on which the instant claim depends requires an M selected from triflate and perrhenate anion. Therefore, the genus “cuprous salt” as recited in claims 2-3 improperly broadens the scope of the Cu(I)-derived salt to include anions other than triflate and perrhenate anion, and therefore the instant claims fail to further limit the subject matter of the claim upon which they depend. Applicant may cancel the claims, amend the claims to place the claims in proper dependent form, rewrite the claims in independent form, or present a sufficient showing that the dependent claims comply with the statutory requirements. Allowable Subject Matter Claims 1-10 would be allowable if rewritten or amended to overcome the objections to claims 2 and 6, the rejection of claim 10 under 35 U.S.C. 101), the rejections of claims 1-10 under 35 U.S.C. 112(b)/35 U.S.C. 112 (pre-AIA ), second paragraph, and the rejections of claims 2-3 under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, set forth in this Office Action. The following is a statement of reasons for the indication of allowable subject matter: The prior art of record does not teach or suggest the claimed polyhedral tungsten/copper/sulfur cluster compound, having a chemical formula of: [RWS3Cu2(La)]n(M)n, wherein R is tris(3,5-dimethylpyrazolyl) hydroborate, tris(pyrazolyl)hydroborate, or pentamethylcyclopentadienyl; La has a structural formula of: PNG media_image2.png 502 810 media_image2.png Greyscale M is selected from triflate (OTf–) and perrhenate (ReO4–), in which when M is ReO4–, n is 4; and when M is OTf–, n is 6, as recited in independent claim 1. The closet prior art is Bao et al. (“Flexible Vertex Engineers the Controlled Assembly of Distorted Supramolecular Tetrahedral and Octahedral Cages”; Research 2022, 2022, 9819343, pages 1-12; published 02-24-2022). Bao teaches the preparation of tungsten/copper/sulfur cluster compounds with tetrahedral or octahedral cage structures [1]X4 (X = BF4–, ClO4–, or PF6–) or [2](SbF6–)6, respectively, from the metal sulfide synthon [Et4N][Tp*WS3] (A), 1,4-di(pyridin-4-yl)buta-1,3-diyne) (L), and [Cu(MeCN)4]X (X = BF4–, ClO4–, PF6–, or SbF6–) (page 3, Figure 2): PNG media_image3.png 519 717 media_image3.png Greyscale The polyhedral compounds of Bao are structurally similar to the recited genus of claim 1 when R is tris(3,5-dimethylpyrazolyl)hydroborate) (abbreviated as Tp*), and La is the ligated structure formed from 1,4-di(pyridin-4-yl)buta-1,3-diyne) and two S atoms of the [Tp*WS3] complex. Bao does not teach a polyhedral tungsten/copper/sulfur cluster compound wherein M is selected from triflate (OTf–) and perrhenate (ReO4–), in which when M is ReO4–, n is 4; and when M is OTf–, n is 6, as recited in independent claim 1. The teachings of Bao do not teach or suggest modifying the disclosed polyhedral compounds by substituting the BF4–, ClO4–, PF6–, or SbF6– counteranions with triflate (OTf–) or perrhenate (ReO4–), as required by the chemical formula of independent claim 1. Furthermore, Zhang et al. (“Rational construction of functional molybdenum (tungsten)-copper-sulfur coordination oligomers and polymers from preformed cluster precursors”; Chem Soc. Rev. 2016, 45, 4995-5019; published 05-13-2016) teaches that the substitution of counterions in functional tungsten-copper-sulfur coordination oligomers is sometimes accompanied by re-orientation of the counterion bridging ligands with elevation of structural complexity, and Zhang does not explicitly teach the strategic implementation of triflate (OTf–) or perrhenate (ReO4–) counteranions in polyhedral tungsten/copper/sulfur cluster compounds (Title; Abstract; page 5002, Col. 1, paragraph 3 and Col. 2, paragraph 1). As such, the skilled artisan would not view the replacement of counterions such as BF4–, ClO4–, PF6–, or SbF6– with triflate (OTf–) or perrhenate (ReO4–) a method of predictably altering or improving the compounds of Bao. Thus, the prior art as a whole does not indicate that the skilled artisan would be sufficiently motivated to modify the compounds of Bao to arrive at the tungsten/copper/sulfur compounds of independent claim 1 with a reasonable expectation of success. Therefore, the claims are free from the prior art for the reasons of record and the reasons set forth above. Conclusion The prior art made of record and not relied upon is considered pertinent to Applicant’s disclosure. Any inquiry concerning this communication or earlier communications from the Examiner should be directed to Derek Rhoades whose telephone number is (703)-756-5321. The Examiner can normally be reached Monday–Thursday, 7:30 am–5:00 pm EST; Friday, 7:30 am–4:00 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the Examiner’s supervisor, Scarlett Goon can be reached on 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /D.R./Examiner, Art Unit 1692 /AMY C BONAPARTE/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

Mar 18, 2024
Application Filed
Sep 09, 2026
Non-Final Rejection mailed — §101, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746237
CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA
2y 9m to grant Granted Sep 29, 2026
Patent 12741934
METHOD FOR THE PREPARATION OF DIARYLMETHANE DYES AND TRIARYLMETHANE DYES INCLUDING ISOSULFAN BLUE
4y 8m to grant Granted Sep 22, 2026
Patent 12741924
PURIFICATION DEVICE
3y 6m to grant Granted Sep 22, 2026
Patent 12729179
PREPARATION METHOD OF SULFUR-CONTAINING BIPHENYL COMPOUND
5y 4m to grant Granted Sep 08, 2026
Patent 12723015
TWO-STAGE PREPARATION PROCESS FOR ?,?-ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS AND PLANT FOR THE PURPOSE
3y 3m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
71%
Grant Probability
88%
With Interview (+17.2%)
3y 6m (~1y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 80 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month